Structure

Physi-Chem Properties

Molecular Weight:  540.27
Volume:  565.656
LogP:  4.344
LogD:  3.229
LogS:  -4.886
# Rotatable Bonds:  7
TPSA:  116.2
# H-Bond Aceptor:  8
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.335
Synthetic Accessibility Score:  5.214
Fsp3:  0.548
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.81
MDCK Permeability:  5.232140756561421e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.049
20% Bioavailability (F20%):  0.932
30% Bioavailability (F30%):  0.669

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.198
Plasma Protein Binding (PPB):  99.63947296142578%
Volume Distribution (VD):  2.683
Pgp-substrate:  5.459565162658691%

ADMET: Metabolism

CYP1A2-inhibitor:  0.054
CYP1A2-substrate:  0.051
CYP2C19-inhibitor:  0.149
CYP2C19-substrate:  0.144
CYP2C9-inhibitor:  0.874
CYP2C9-substrate:  0.384
CYP2D6-inhibitor:  0.093
CYP2D6-substrate:  0.1
CYP3A4-inhibitor:  0.892
CYP3A4-substrate:  0.574

ADMET: Excretion

Clearance (CL):  3.267
Half-life (T1/2):  0.316

ADMET: Toxicity

hERG Blockers:  0.037
Human Hepatotoxicity (H-HT):  0.961
Drug-inuced Liver Injury (DILI):  0.954
AMES Toxicity:  0.009
Rat Oral Acute Toxicity:  0.491
Maximum Recommended Daily Dose:  0.884
Skin Sensitization:  0.136
Carcinogencity:  0.047
Eye Corrosion:  0.005
Eye Irritation:  0.037
Respiratory Toxicity:  0.459

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC272946

Natural Product ID:  NPC272946
Common Name*:   Pubescene D
IUPAC Name:   [(1S,2R,3aR,5E,9R,11R,12E,13aS)-1,9-diacetyloxy-3a-hydroxy-2,5,8,8,12-pentamethyl-4-oxo-1,2,3,7,9,10,11,13a-octahydrocyclopenta[12]annulen-11-yl] benzoate
Synonyms:   Pubescene D
Standard InCHIKey:  UAKCWZDVHJZVRU-CJSPNJQUSA-N
Standard InCHI:  InChI=1S/C31H40O8/c1-18-13-14-30(6,7)26(37-21(4)32)16-25(39-29(35)23-11-9-8-10-12-23)19(2)15-24-27(38-22(5)33)20(3)17-31(24,36)28(18)34/h8-13,15,20,24-27,36H,14,16-17H2,1-7H3/b18-13+,19-15+/t20-,24+,25-,26-,27+,31-/m1/s1
SMILES:  C/C/1=CCC(C)(C)[C@@H](C[C@H](/C(=C/[C@H]2[C@H]([C@H](C)C[C@@]2(C1=O)O)OC(=O)C)/C)OC(=O)c1ccccc1)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL488000
PubChem CID:   10370059
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0002877] Jatrophane and cyclojatrophane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11807 Euphorbia pubescens Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[15165162]
NPO11807 Euphorbia pubescens Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO11807 Euphorbia pubescens Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens GI50 = 37500.0 nM PMID[490073]
NPT397 Cell Line NCI-H460 Homo sapiens GI50 = 37500.0 nM PMID[490073]
NPT395 Cell Line SF-268 Homo sapiens GI50 = 90120.0 nM PMID[490073]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC272946 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9603 High Similarity NPC477364
0.9528 High Similarity NPC477368
0.9528 High Similarity NPC477359
0.9453 High Similarity NPC477367
0.9453 High Similarity NPC232888
0.9365 High Similarity NPC42234
0.9302 High Similarity NPC472247
0.9242 High Similarity NPC473497
0.9219 High Similarity NPC477360
0.9194 High Similarity NPC477362
0.9154 High Similarity NPC475262
0.9154 High Similarity NPC265459
0.9154 High Similarity NPC290833
0.9154 High Similarity NPC270364
0.9104 High Similarity NPC45307
0.9104 High Similarity NPC153214
0.9098 High Similarity NPC475413
0.9098 High Similarity NPC474303
0.9084 High Similarity NPC285221
0.9084 High Similarity NPC194769
0.9077 High Similarity NPC472250
0.9048 High Similarity NPC477363
0.9048 High Similarity NPC477366
0.9015 High Similarity NPC86772
0.8976 High Similarity NPC477357
0.8976 High Similarity NPC477365
0.8947 High Similarity NPC325805
0.8947 High Similarity NPC272523
0.8947 High Similarity NPC276652
0.8939 High Similarity NPC477358
0.8923 High Similarity NPC239358
0.8923 High Similarity NPC233860
0.8906 High Similarity NPC477370
0.8905 High Similarity NPC170668
0.8881 High Similarity NPC475660
0.8881 High Similarity NPC251294
0.8855 High Similarity NPC472248
0.8841 High Similarity NPC205389
0.8837 High Similarity NPC37968
0.8815 High Similarity NPC473654
0.8788 High Similarity NPC28836
0.8788 High Similarity NPC311492
0.8779 High Similarity NPC233692
0.874 High Similarity NPC8990
0.8722 High Similarity NPC79699
0.8722 High Similarity NPC200154
0.8714 High Similarity NPC477097
0.8714 High Similarity NPC477101
0.8714 High Similarity NPC25484
0.8714 High Similarity NPC125033
0.8714 High Similarity NPC232583
0.8714 High Similarity NPC477099
0.8686 High Similarity NPC477096
0.8686 High Similarity NPC82467
0.8686 High Similarity NPC477094
0.8676 High Similarity NPC242355
0.8672 High Similarity NPC477369
0.8657 High Similarity NPC202729
0.8626 High Similarity NPC475508
0.8593 High Similarity NPC27721
0.854 High Similarity NPC187566
0.8538 High Similarity NPC472706
0.8531 High Similarity NPC477098
0.8531 High Similarity NPC477100
0.8529 High Similarity NPC473301
0.8507 High Similarity NPC153617
0.85 High Similarity NPC477095
0.8485 Intermediate Similarity NPC475452
0.8485 Intermediate Similarity NPC475671
0.8473 Intermediate Similarity NPC472707
0.845 Intermediate Similarity NPC472704
0.8372 Intermediate Similarity NPC472703
0.837 Intermediate Similarity NPC134937
0.837 Intermediate Similarity NPC298547
0.837 Intermediate Similarity NPC324898
0.837 Intermediate Similarity NPC329913
0.8346 Intermediate Similarity NPC472708
0.8309 Intermediate Similarity NPC279637
0.8309 Intermediate Similarity NPC149401
0.8288 Intermediate Similarity NPC70344
0.8261 Intermediate Similarity NPC170718
0.8248 Intermediate Similarity NPC52523
0.8248 Intermediate Similarity NPC217673
0.8235 Intermediate Similarity NPC126516
0.8219 Intermediate Similarity NPC469456
0.8214 Intermediate Similarity NPC183540
0.8214 Intermediate Similarity NPC51181
0.8209 Intermediate Similarity NPC122504
0.8209 Intermediate Similarity NPC3450
0.8197 Intermediate Similarity NPC469636
0.8188 Intermediate Similarity NPC327511
0.8188 Intermediate Similarity NPC205305
0.8182 Intermediate Similarity NPC476599
0.8156 Intermediate Similarity NPC95449
0.814 Intermediate Similarity NPC473243
0.8133 Intermediate Similarity NPC55744
0.8129 Intermediate Similarity NPC53361
0.8129 Intermediate Similarity NPC121268
0.8102 Intermediate Similarity NPC203486
0.8085 Intermediate Similarity NPC475135
0.8074 Intermediate Similarity NPC82712
0.8042 Intermediate Similarity NPC127857
0.8016 Intermediate Similarity NPC153053
0.8016 Intermediate Similarity NPC307651
0.8015 Intermediate Similarity NPC72915
0.8 Intermediate Similarity NPC270699
0.8 Intermediate Similarity NPC82899
0.8 Intermediate Similarity NPC9905
0.7985 Intermediate Similarity NPC169913
0.797 Intermediate Similarity NPC246166
0.797 Intermediate Similarity NPC295664
0.7959 Intermediate Similarity NPC138641
0.7959 Intermediate Similarity NPC22571
0.7959 Intermediate Similarity NPC283875
0.7959 Intermediate Similarity NPC469648
0.7959 Intermediate Similarity NPC469647
0.7958 Intermediate Similarity NPC182869
0.7943 Intermediate Similarity NPC162613
0.7943 Intermediate Similarity NPC87934
0.7939 Intermediate Similarity NPC50872
0.7926 Intermediate Similarity NPC51448
0.7926 Intermediate Similarity NPC115797
0.7923 Intermediate Similarity NPC204784
0.7922 Intermediate Similarity NPC161151
0.792 Intermediate Similarity NPC1082
0.792 Intermediate Similarity NPC305912
0.7917 Intermediate Similarity NPC134131
0.7917 Intermediate Similarity NPC478264
0.7917 Intermediate Similarity NPC25043
0.791 Intermediate Similarity NPC275576
0.7902 Intermediate Similarity NPC131966
0.7902 Intermediate Similarity NPC191387
0.7891 Intermediate Similarity NPC161955
0.7891 Intermediate Similarity NPC472398
0.7891 Intermediate Similarity NPC51602
0.7891 Intermediate Similarity NPC471103
0.7887 Intermediate Similarity NPC266374
0.7877 Intermediate Similarity NPC250046
0.7877 Intermediate Similarity NPC60509
0.7877 Intermediate Similarity NPC81698
0.7862 Intermediate Similarity NPC478263
0.7857 Intermediate Similarity NPC321852
0.7852 Intermediate Similarity NPC469730
0.7852 Intermediate Similarity NPC473632
0.7852 Intermediate Similarity NPC473611
0.7852 Intermediate Similarity NPC132599
0.7842 Intermediate Similarity NPC48929
0.784 Intermediate Similarity NPC93084
0.784 Intermediate Similarity NPC196246
0.784 Intermediate Similarity NPC251854
0.784 Intermediate Similarity NPC214067
0.7838 Intermediate Similarity NPC233581
0.7838 Intermediate Similarity NPC145649
0.7832 Intermediate Similarity NPC192658
0.7826 Intermediate Similarity NPC125153
0.7823 Intermediate Similarity NPC161239
0.7823 Intermediate Similarity NPC112216
0.7823 Intermediate Similarity NPC165260
0.7823 Intermediate Similarity NPC198455
0.7823 Intermediate Similarity NPC7095
0.781 Intermediate Similarity NPC471832
0.78 Intermediate Similarity NPC11410
0.7795 Intermediate Similarity NPC161611
0.7793 Intermediate Similarity NPC471100
0.7793 Intermediate Similarity NPC471107
0.7793 Intermediate Similarity NPC471162
0.7787 Intermediate Similarity NPC474365
0.7787 Intermediate Similarity NPC301943
0.7786 Intermediate Similarity NPC477893
0.7786 Intermediate Similarity NPC477896
0.7778 Intermediate Similarity NPC477894
0.7778 Intermediate Similarity NPC260818
0.777 Intermediate Similarity NPC472656
0.777 Intermediate Similarity NPC101043
0.777 Intermediate Similarity NPC306799
0.7761 Intermediate Similarity NPC471466
0.776 Intermediate Similarity NPC17417
0.776 Intermediate Similarity NPC83628
0.776 Intermediate Similarity NPC10251
0.776 Intermediate Similarity NPC265407
0.7754 Intermediate Similarity NPC470278
0.774 Intermediate Similarity NPC475552
0.774 Intermediate Similarity NPC312393
0.7734 Intermediate Similarity NPC474363
0.7733 Intermediate Similarity NPC251139
0.7733 Intermediate Similarity NPC21410
0.7733 Intermediate Similarity NPC473670
0.7733 Intermediate Similarity NPC282239
0.7724 Intermediate Similarity NPC34943
0.7721 Intermediate Similarity NPC473220
0.7721 Intermediate Similarity NPC470753
0.7721 Intermediate Similarity NPC204579
0.7708 Intermediate Similarity NPC472546
0.7703 Intermediate Similarity NPC476173
0.7697 Intermediate Similarity NPC159692
0.7692 Intermediate Similarity NPC473440
0.7692 Intermediate Similarity NPC90614
0.7692 Intermediate Similarity NPC97667
0.7692 Intermediate Similarity NPC171207
0.7692 Intermediate Similarity NPC472547

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC272946 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8561 High Similarity NPD7236 Approved
0.8392 Intermediate Similarity NPD7239 Suspended
0.792 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7881 Intermediate Similarity NPD7057 Phase 3
0.7881 Intermediate Similarity NPD7058 Phase 2
0.7852 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.776 Intermediate Similarity NPD2182 Approved
0.7547 Intermediate Similarity NPD7799 Discontinued
0.7538 Intermediate Similarity NPD690 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5738 Clinical (unspecified phase)
0.7464 Intermediate Similarity NPD5740 Clinical (unspecified phase)
0.7464 Intermediate Similarity NPD6085 Phase 2
0.746 Intermediate Similarity NPD6685 Approved
0.7447 Intermediate Similarity NPD7961 Discontinued
0.744 Intermediate Similarity NPD164 Approved
0.7422 Intermediate Similarity NPD2067 Discontinued
0.7407 Intermediate Similarity NPD7457 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD6647 Phase 2
0.7344 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD2629 Approved
0.7222 Intermediate Similarity NPD5765 Approved
0.7206 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD6912 Phase 3
0.7176 Intermediate Similarity NPD1609 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD1237 Approved
0.7143 Intermediate Similarity NPD6362 Approved
0.7121 Intermediate Similarity NPD7094 Approved
0.7121 Intermediate Similarity NPD6858 Approved
0.712 Intermediate Similarity NPD1238 Approved
0.7101 Intermediate Similarity NPD6287 Discontinued
0.7095 Intermediate Similarity NPD7702 Clinical (unspecified phase)
0.709 Intermediate Similarity NPD4198 Discontinued
0.7075 Intermediate Similarity NPD7305 Phase 1
0.7063 Intermediate Similarity NPD7008 Discontinued
0.7059 Intermediate Similarity NPD6273 Approved
0.7059 Intermediate Similarity NPD9545 Approved
0.6984 Remote Similarity NPD2066 Phase 3
0.698 Remote Similarity NPD6006 Clinical (unspecified phase)
0.698 Remote Similarity NPD6005 Phase 3
0.698 Remote Similarity NPD6003 Clinical (unspecified phase)
0.698 Remote Similarity NPD6004 Phase 3
0.698 Remote Similarity NPD6002 Phase 3
0.6972 Remote Similarity NPD5647 Approved
0.6954 Remote Similarity NPD4628 Phase 3
0.6953 Remote Similarity NPD1930 Approved
0.6953 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6953 Remote Similarity NPD1929 Approved
0.6939 Remote Similarity NPD6653 Approved
0.6935 Remote Similarity NPD1693 Approved
0.6934 Remote Similarity NPD7741 Discontinued
0.6913 Remote Similarity NPD7137 Phase 2
0.6905 Remote Similarity NPD9495 Approved
0.6889 Remote Similarity NPD5951 Approved
0.6871 Remote Similarity NPD6355 Discontinued
0.6867 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6857 Remote Similarity NPD4806 Approved
0.6857 Remote Similarity NPD4807 Approved
0.6855 Remote Similarity NPD5761 Phase 2
0.6855 Remote Similarity NPD5122 Clinical (unspecified phase)
0.6855 Remote Similarity NPD5760 Phase 2
0.6849 Remote Similarity NPD6663 Approved
0.6845 Remote Similarity NPD6765 Approved
0.6845 Remote Similarity NPD6764 Approved
0.6845 Remote Similarity NPD8368 Discontinued
0.6845 Remote Similarity NPD7685 Pre-registration
0.6835 Remote Similarity NPD5306 Approved
0.6835 Remote Similarity NPD5305 Approved
0.6824 Remote Similarity NPD8407 Phase 2
0.6815 Remote Similarity NPD2652 Approved
0.6815 Remote Similarity NPD2650 Approved
0.6812 Remote Similarity NPD7009 Phase 2
0.6809 Remote Similarity NPD3972 Approved
0.6806 Remote Similarity NPD3662 Phase 3
0.6806 Remote Similarity NPD5736 Approved
0.6806 Remote Similarity NPD3661 Approved
0.6806 Remote Similarity NPD3664 Approved
0.6806 Remote Similarity NPD3663 Approved
0.6791 Remote Similarity NPD969 Suspended
0.6788 Remote Similarity NPD9493 Approved
0.6781 Remote Similarity NPD3764 Approved
0.6774 Remote Similarity NPD1088 Approved
0.6772 Remote Similarity NPD6599 Discontinued
0.6769 Remote Similarity NPD5909 Discontinued
0.6759 Remote Similarity NPD6832 Phase 2
0.6748 Remote Similarity NPD9256 Approved
0.6748 Remote Similarity NPD9258 Approved
0.6744 Remote Similarity NPD8434 Phase 2
0.6739 Remote Similarity NPD7610 Discontinued
0.6733 Remote Similarity NPD2799 Discontinued
0.6716 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6713 Remote Similarity NPD1876 Approved
0.6709 Remote Similarity NPD7458 Discontinued
0.6691 Remote Similarity NPD6010 Discontinued
0.6688 Remote Similarity NPD3887 Approved
0.6686 Remote Similarity NPD6784 Approved
0.6686 Remote Similarity NPD6785 Approved
0.6667 Remote Similarity NPD4136 Approved
0.6667 Remote Similarity NPD2569 Approved
0.6667 Remote Similarity NPD3268 Approved
0.6667 Remote Similarity NPD2567 Approved
0.6667 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6667 Remote Similarity NPD2313 Discontinued
0.6667 Remote Similarity NPD4135 Approved
0.6667 Remote Similarity NPD4106 Approved
0.6647 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6646 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6644 Remote Similarity NPD230 Phase 1
0.6643 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6626 Remote Similarity NPD7075 Discontinued
0.6622 Remote Similarity NPD7713 Phase 3
0.6615 Remote Similarity NPD1932 Approved
0.6613 Remote Similarity NPD1089 Approved
0.6613 Remote Similarity NPD1086 Approved
0.6613 Remote Similarity NPD1090 Approved
0.6603 Remote Similarity NPD6799 Approved
0.6597 Remote Similarity NPD5667 Approved
0.6596 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6591 Remote Similarity NPD5048 Discontinued
0.659 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6587 Remote Similarity NPD1202 Approved
0.6581 Remote Similarity NPD2354 Approved
0.6581 Remote Similarity NPD6190 Approved
0.6575 Remote Similarity NPD5204 Approved
0.6573 Remote Similarity NPD9717 Approved
0.6571 Remote Similarity NPD8435 Approved
0.6571 Remote Similarity NPD8360 Approved
0.6571 Remote Similarity NPD8361 Approved
0.6568 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6567 Remote Similarity NPD2329 Discontinued
0.6561 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6557 Remote Similarity NPD9259 Approved
0.6557 Remote Similarity NPD9257 Approved
0.6552 Remote Similarity NPD2797 Approved
0.6543 Remote Similarity NPD7819 Suspended
0.6536 Remote Similarity NPD2346 Discontinued
0.6536 Remote Similarity NPD5763 Approved
0.6536 Remote Similarity NPD5762 Approved
0.6532 Remote Similarity NPD800 Approved
0.6531 Remote Similarity NPD7055 Discontinued
0.6525 Remote Similarity NPD4105 Approved
0.6525 Remote Similarity NPD4102 Approved
0.6522 Remote Similarity NPD4766 Approved
0.6519 Remote Similarity NPD1317 Discontinued
0.6516 Remote Similarity NPD8166 Discontinued
0.6513 Remote Similarity NPD7033 Discontinued
0.651 Remote Similarity NPD6233 Phase 2
0.6507 Remote Similarity NPD2798 Approved
0.6506 Remote Similarity NPD8127 Discontinued
0.649 Remote Similarity NPD3528 Clinical (unspecified phase)
0.6486 Remote Similarity NPD6039 Approved
0.6485 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6484 Remote Similarity NPD1989 Approved
0.6483 Remote Similarity NPD2198 Approved
0.6483 Remote Similarity NPD2199 Approved
0.6481 Remote Similarity NPD6801 Discontinued
0.648 Remote Similarity NPD3672 Approved
0.648 Remote Similarity NPD3673 Approved
0.6471 Remote Similarity NPD6649 Approved
0.6471 Remote Similarity NPD6650 Approved
0.6471 Remote Similarity NPD2935 Discontinued
0.6467 Remote Similarity NPD4140 Approved
0.6458 Remote Similarity NPD6637 Approved
0.6458 Remote Similarity NPD1608 Approved
0.6457 Remote Similarity NPD8150 Discontinued
0.6456 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6456 Remote Similarity NPD2534 Approved
0.6456 Remote Similarity NPD2533 Approved
0.6456 Remote Similarity NPD2532 Approved
0.6443 Remote Similarity NPD6798 Discontinued
0.6443 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6438 Remote Similarity NPD3266 Approved
0.6438 Remote Similarity NPD3267 Approved
0.6429 Remote Similarity NPD2355 Clinical (unspecified phase)
0.6429 Remote Similarity NPD2353 Approved
0.642 Remote Similarity NPD7411 Suspended
0.6419 Remote Similarity NPD4617 Approved
0.6419 Remote Similarity NPD4620 Approved
0.6419 Remote Similarity NPD5201 Approved
0.6419 Remote Similarity NPD5203 Approved
0.641 Remote Similarity NPD4110 Phase 3
0.641 Remote Similarity NPD7488 Clinical (unspecified phase)
0.641 Remote Similarity NPD7003 Approved
0.641 Remote Similarity NPD6398 Clinical (unspecified phase)
0.641 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6405 Remote Similarity NPD4308 Phase 3
0.64 Remote Similarity NPD8032 Phase 2
0.64 Remote Similarity NPD7715 Approved
0.64 Remote Similarity NPD5347 Phase 2
0.64 Remote Similarity NPD7714 Approved
0.64 Remote Similarity NPD5346 Phase 2
0.6398 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6397 Remote Similarity NPD4233 Approved
0.6397 Remote Similarity NPD4234 Approved
0.6395 Remote Similarity NPD1019 Discontinued
0.6377 Remote Similarity NPD5277 Phase 2
0.6376 Remote Similarity NPD7095 Approved
0.6375 Remote Similarity NPD5403 Approved
0.6371 Remote Similarity NPD1087 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data